Cited by 860Cancer, Hypoxia, and MetabolismAmino Acid Enzymes and MetabolismBacterial Cancer Therapy

The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.

Glutaminolysis: A Hallmark of Cancer Metabolism

Open access

Yang, Lifeng, Venneti, Sriram, Nagrath, Deepak·2017·Annual Review of Biomedical Engineering

DOI 10.1146/annurev-bioeng-071516-044546

Open this paper in CoChat — free account Open PDF

Abstract

Glutamine is the most abundant circulating amino acid in blood and muscle and is critical for many fundamental cell functions in cancer cells, including synthesis of metabolites that maintain mitochondrial metabolism; generation of antioxidants to remove reactive oxygen species; synthesis of nonessential amino acids (NEAAs), purines, pyrimidines, and fatty acids for cellular replication; and activation of cell signaling. In light of the pleiotropic role of glutamine in cancer cells, a comprehensive understanding of glutamine metabolism is essential for the development of metabolic therapeutic strategies for targeting cancer cells. In this article, we review oncogene-, tumor suppressor–, and tumor microenvironment–mediated regulation of glutamine metabolism in cancer cells. We describe the mechanism of glutamine's regulation of tumor proliferation, metastasis, and global methylation. Furthermore, we highlight the therapeutic potential of glutamine metabolism and emphasize that clinical application of in vivo assessment of glutamine metabolism is critical for identifying new ways to treat patients through glutamine-based metabolic therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1146/annurev-bioeng-071516-044546

Cites

171 of 171 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
On the origin of cancer cells
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 3×
“In order to systematically understand the role of metabolic reprogramming in cancer cells on establishing and maintaining a tumorigenic status, Pavlova & Thompson (2) summarized”
Background
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
p53, guardian of the genome
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 1×
“As tumors develop, cancer cells recruit nonmalignant stromal cells in their vicinity to form a highly interactive tumor microenvironment (137).”
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
On Respiratory Impairment in Cancer Cells
Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472

Show all 171 references

Research works printed but not linked: 8

Smolke CD, 2010, The Metabolic Pathway Engineering Handbook: Fundamentals
Matsuno T, 1992, Cancer Res, 52, 1192
10.1038/nature12040 · DOI · Paper page
10.1016/j.cell.2015.07.016 · DOI · Paper page
Pizer ES, 1996, Cancer Res, 56, 1189
Levine B, 2015, J. Clin. Investig., 12514
Majós C, 2004, Am. J. Neuroradiol., 25, 1696
10.1158/1535-7163.MCT-13-0870 · DOI · Paper page

Sorted by citations

Items 101–200 of 860

Neddylation inhibition induces glutamine uptake and metabolism by targeting CRL3SPOP E3 ligase in cancer cells
Zhou, Q., Lin, W., Wang, C., Sun, F., Ju, S., Chen, Q., Wang, Y., Chen, Y., Li, H., Wang, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30559-2 · Cited by 80
The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors
Liaghat, M., Ferdousmakan, S., Mortazavi, S. H., Yahyazadeh, S., Irani, A., Banihashemi, S., Asl, F. S. S., Akbari, A., Farzam, F., Aziziyan, F., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01957-4 · Cited by 87
Inhibition of Glutaminase 1 Attenuates Experimental Pulmonary Fibrosis
Cui, H., Xie, N., Jiang, D., Banerjee, S., Ge, J., Sanders, Y. Y., & Liu, G. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0051oc · Cited by 76
ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma
Marshall, A. D., van Geldermalsen, M., Otte, N. J., Lum, T., Vellozzi, M., Thoeng, A., Pang, A., Nagarajah, R., Zhang, B. K., Wang, Q., et al. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.70 · Cited by 79
Mitochondria as multifaceted regulators of ferroptosis
Guo, J., Zhou, Y., Liu, D., Wang, M., Wu, Y., Tang, D., & Liu, X. (2022) · Life Metabolism · doi:10.1093/lifemeta/loac035 · Cited by 83
The role of OXCT1 in the pathogenesis of cancer as a rate-limiting enzyme of ketone body metabolism
Zhang, S., & Xie, C. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.07.003 · Cited by 76
Deoxyribonucleotide Triphosphate Metabolism in Cancer and Metabolic Disease
Buj, R., & Aird, K. M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00177 · Cited by 76
Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma
Hanaford, A. R., Alt, J., Rais, R., Wang, S. Z., Kaur, H., Thorek, D. L. J., Eberhart, C. G., Slusher, B. S., Martin, A. M., & Raabe, E. H. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.05.013 · Cited by 74
Tumor Microenvironment-Responsive, Multistaged Liposome Induces Apoptosis and Ferroptosis by Amplifying Oxidative Stress for Enhanced Cancer Therapy
Kou, L., Sun, R., Jiang, X., Lin, X., Huang, H., Bao, S., Zhang, Y., Li, C., Chen, R., & Yao, Q. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c03564 · Cited by 73
Inhibition of glutaminolysis in combination with other therapies to improve cancer treatment
Shen, Y., Chen, C., Huang, Y., Evans, E. E., Cheng, C., Chuang, Y.-J., Zhang, C., & Le, A. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.01.006 · Cited by 75
Ultrasound (US)-activated redox dyshomeostasis therapy reinforced by immunogenic cell death (ICD) through a mitochondrial targeting liposomal nanosystem
Ren, J., Zhou, J., Liu, H., Jiao, X., Cao, Y., Xu, Z., Kang, Y., & Xue, P. (2021) · Theranostics · doi:10.7150/thno.62984 · Cited by 73
Low-dose exposure to phytosynthesized gold nanoparticles combined with glutamine deprivation enhances cell death in the cancer cell line HeLa via oxidative stress-mediated mitochondrial dysfunction and G0/G1 cell cycle arrest
Prasad, A., Khatua, A., Mohanta, Y. K., Saravanan, M., Meena, R., & Ghosh, I. (2022) · Nanoscale · doi:10.1039/d2nr02150a · Cited by 72
The Role of Hypoxia-Inducible Factor-1 Alpha in Renal Disease
Liu, H., Li, Y., & Xiong, J. (2022) · Molecules · doi:10.3390/molecules27217318 · Cited by 73
Glutamine metabolism in diseases associated with mitochondrial dysfunction
Bornstein, R., Mulholland, M. T., Sedensky, M. M., Morgan, P. G., & Johnson, S. C. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103887 · Cited by 73
Deregulated transcription factors in cancer cell metabolisms and reprogramming
Kant, R., Manne, R., Anas, M., Penugurti, V., Chen, T., Pan, B., Hsu, C.-C., & Lin, H. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.001 · Cited by 76
Nutrient sensors and their crosstalk
Sung, Y., Yu, Y. C., & Han, J. M. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01006-z · Cited by 73
Glutathione-Dependent Pathways in Cancer Cells
Kalinina, E. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158423 · Cited by 81
Targeting KRAS: from metabolic regulation to cancer treatment
Shi, Y., Zheng, H., Wang, T., Zhou, S., Zhao, S., Li, M., & Cao, B. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02216-3 · Cited by 82
At the Crossroads of Apoptosis and Autophagy: Multiple Roles of the Co-Chaperone BAG3 in Stress and Therapy Resistance of Cancer
Kögel, D., Linder, B., Brunschweiger, A., Chines, S., & Behl, C. (2020) · Cells · doi:10.3390/cells9030574 · Cited by 72
Regulation of Ferroptosis by Amino Acid Metabolism in Cancer
Yang, J., Dai, X., Xu, H., Tang, Q., & Bi, F. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.64982 · Cited by 70
Cancer depends on fatty acids for ATP production: A possible link between cancer and obesity
Lee, H., Woo, S. M., Jang, H., Kang, M., & Kim, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.07.005 · Cited by 71
Metabolic Reprogramming in Thyroid Carcinoma
Coelho, R. G., Fortunato, R. S., & de Carvalho, D. P. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00082 · Cited by 67
Role of glutamine and its metabolite ammonia in crosstalk of cancer-associated fibroblasts and cancer cells
Li, X., Zhu, H., Sun, W., Yang, X., Nie, Q. H., & Fang, X. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02121-5 · Cited by 69
Intracellular energy controls dynamics of stress-induced ribonucleoprotein granules
Wang, T., Tian, X., Kim, H. B., Jang, Y., Huang, Z., Na, C. H., & Wang, J. (2022) · Nature Communications · doi:10.1038/s41467-022-33079-1 · Cited by 71
Cellular metabolism: A key player in cancer ferroptosis
Jiang, X., Peng, Q., Peng, M., Oyang, L., Wang, H., Liu, Q., Xu, X., Wu, N., Tan, S., Yang, W., et al. (2024) · 癌症：英文版 · doi:10.1002/cac2.12519 · Cited by 67
Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma
Zhao, C., Wang, B., Liu, E., & Zhang, Z. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00622-w · Cited by 67
Inhibition of ASCT2 induces hepatic stellate cell senescence with modified proinflammatory secretome through an IL-1α/NF-κB feedback pathway to inhibit liver fibrosis
Wang, F., Li, Z., Chen, L., Yang, T., Liang, B., Zhang, Z., Shao, J., Xu, X., Yin, G., Wang, S., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.03.014 · Cited by 72
Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses
Chaudhary, V., Kioon, M. D. A., Hwang, S., Mishra, B., Lakin, K. S., Kirou, K. A., Zhang-Sun, J., Wiseman, R. L., Spiera, R., Crow, M. K., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20221085 · Cited by 69
The Warburg effect modulates DHODH role in ferroptosis: a review
Amos, A., Amos, A., Wu, L., & He, X. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-022-01025-9 · Cited by 67
Metabolomics study of oral cancers
Chen, X., & Yu, D. (2019) · Metabolomics · doi:10.1007/s11306-019-1483-8 · Cited by 69
Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer
Demas, D. M., Demo, S. D., Fallah, Y., Clarke, R. C., Nephew, K. P., Althouse, S. K., Sandusky, G. E., He, W., & Shajahan‐Haq, A. N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00686 · Cited by 71
Serum Metabolomics Study of Papillary Thyroid Carcinoma Based on HPLC-Q-TOF-MS/MS
Du, Y., Fan, P., Zou, L., Jiang, Y., Gu, X., Yu, J., & Zhang, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.593510 · Cited by 66
A Role of Tumor-Released Exosomes in Paracrine Dissemination and Metastasis
Spugnini, E. P., Logozzi, M., Raimo, R. D., Mizzoni, D., & Fais, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123968 · Cited by 66
The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma
Evan, T., Wang, V. M.-Y., & Behrens, A. (2022) · Oncogene · doi:10.1038/s41388-022-02448-x · Cited by 69
The CRL3 KCTD10 ubiquitin ligase–USP18 axis coordinately regulates cystine uptake and ferroptosis by modulating SLC7A11
Zhou, Q., Yu, H., Chen, Y., Ren, J., Lü, Y., & Sun, Y. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2320655121 · Cited by 67
Deciphering metabolic rewiring in breast cancer subtypes
Ogrodzinski, M. P., Bernard, J. J., & Lunt, S. Y. (2017) · Translational research · doi:10.1016/j.trsl.2017.07.004 · Cited by 67
The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism
Xu, Y., Qiu, M., Shen, M., Dong, S., Ye, G., Shi, X., & Sun, M. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.03.017 · Cited by 65
ASCT2 and LAT1 Contribution to the Hallmarks of Cancer: From a Molecular Perspective to Clinical Translation
Lopes, C., Pereira, C., & Medeiros, R. (2021) · Cancers · doi:10.3390/cancers13020203 · Cited by 63
Oxidative stress regulation and related metabolic pathways in epithelial–mesenchymal transition of breast cancer stem cells
Farahzadi, R., Valipour, B., Fathi, E., Pirmoradi, S., Molavi, O., Montazersaheb, S., & Sanaat, Z. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03571-6 · Cited by 65
Nitric oxide and tumor metabolic reprogramming
Lopez-Sanchez, L. M., Aranda, E., & Rodríguez‐Ariza, A. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113769 · Cited by 63
Glutathione Synthesis in Cancer Cells
Kalinina, E. V., & Гаврилюк, Л. А. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297920080052 · Cited by 62
KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
Zhang, Z., Zhang, H., Liao, X., & Tsai, H. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1147676 · Cited by 62
α-KG inhibits tumor growth of diffuse large B-cell lymphoma by inducing ROS and TP53-mediated ferroptosis
Cai, Y., Lv, L., Lu, T., Ding, M., Yu, Z., Chen, X., Zhou, X., & Wang, X. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01475-1 · Cited by 61
Effects of glutamine deprivation on oxidative stress and cell survival in breast cell lines
Gwangwa, M. V., Joubert, A. M., & Visagie, M. H. (2019) · Biological Research · doi:10.1186/s40659-019-0224-9 · Cited by 57
In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinoma
Kaushik, A., Tarangelo, A., Boroughs, L. K., Ragavan, M., Zhang, Y., Wu, C., Li, X., Ahumada, K., Chiang, J., Tcheuyap, V. T., et al. (2022) · Science Advances · doi:10.1126/sciadv.abp8293 · Cited by 56
Metabolic dependencies and targets in ovarian cancer
Zhang, Y., Wang, Y., Zhao, G., Oršulić, S., & Matei, D. E. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108413 · Cited by 65
NKX2-8 deletion-induced reprogramming of fatty acid metabolism confers chemoresistance in epithelial ovarian cancer
Zhu, J., Wu, G., Song, L., Cao, L., Tan, Z., Tang, M., Li, Z., Shi, D., Zhang, S., & Li, J. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.04.041 · Cited by 58
Role of stress granules in tumorigenesis and cancer therapy
Li, T., Zeng, Z., Fan, C., & Xiong, W. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189006 · Cited by 56
13 C metabolite tracing reveals glutamine and acetate as critical in vivo fuels for CD8 T cells
Ma, E. H., Dahabieh, M. S., DeCamp, L. M., Kaymak, I., Kitchen-Goosen, S. M., Oswald, B. M., Longo, J., Roy, D. G., Verway, M. J., Johnson, R. M., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj1431 · Cited by 53
Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target
van Niekerk, G., & Engelbrecht, A. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0383-7 · Cited by 60
The pathways related to glutamine metabolism, glutamine inhibitors and their implication for improving the efficiency of chemotherapy in triple-negative breast cancer
Delgir, S., Bastami, M., Ilkhani, K., Safi, A., Seif, F., & Alivand, M. R. (2021) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2021.108366 · Cited by 60
Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations
Hvinden, I. C., Cadoux-Hudson, T. A. D., Schofield, C. J., & McCullagh, J. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100469 · Cited by 64
Inhibiting xCT/SLC7A11 induces ferroptosis of myofibroblastic hepatic stellate cells but exacerbates chronic liver injury
Du, K., Oh, S., Dutta, R. K., Sun, T., Yang, W., Chi, J., & Diehl, A. M. (2021) · Liver International · doi:10.1111/liv.14945 · Cited by 61
Aspartate metabolism in endothelial cells activates the mTORC1 pathway to initiate translation during angiogenesis
Oberkersch, R. E., Pontarin, G., Astone, M., Spizzotin, M., Arslanbaeva, L. R., Tosi, G., Panieri, E., Ricciardi, S., Allega, M. F., Brossa, A., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.04.018 · Cited by 55
Metabolic regulation of T cells in the tumor microenvironment by nutrient availability and diet
Zhao, S., Peralta, R. M., Avina-Ochoa, N., Delgoffe, G. M., & Kaech, S. M. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101485 · Cited by 58
Endogenous toxic metabolites and implications in cancer therapy
Lee, N., Spears, M. E., Carlisle, A. E., & Kim, D. (2020) · Oncogene · doi:10.1038/s41388-020-01395-9 · Cited by 56
Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges
Xu, L., Cao, Y., Ya, X., Li, R., & Xu, X. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202300238 · Cited by 54
The Tricarboxylic Acid Cycle Metabolites for Cancer: Friend or Enemy
Wu, J., Liu, N., Chen, J., Tao, Q., Li, Q., Li, J., Chen, X., & Peng, C. (2024) · Research · doi:10.34133/research.0351 · Cited by 57
Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
Yin, J., Markert, J. M., & Leavenworth, J. W. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00136 · Cited by 55
Ovarian cancer modulates the immunosuppressive function of CD11b+Gr1+ myeloid cells via glutamine metabolism
Udumula, M. P., Sakr, S., Dar, S. A., Alvero, A. B., Ali‐Fehmi, R., Abdulfatah, E., Li, J., Jiang, J., Tang, A., Buekers, T., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101272 · Cited by 54
Targeting the glutamine-arginine-proline metabolism axis in cancer
Wang, D., Duan, J., Guo, Y., Chen, J., Chen, T.-Q., Wang, J., & Yu, S. (2024) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2024.2367129 · Cited by 56
Remarkable metabolic reorganization and altered metabolic requirements in frog metamorphic climax
Zhu, W., Chang, L., Zhao, T., Wang, B., & Jiang, J. (2020) · Frontiers in Zoology · doi:10.1186/s12983-020-00378-6 · Cited by 52
SLC15A4 mediates M1-prone metabolic shifts in macrophages and guards immune cells from metabolic stress
Kobayashi, T., Nguyen-Tien, D., Sorimachi, Y., Sugiura, Y., Suzuki, T., Karyu, H., Shimabukuro-Demoto, S., Uemura, T., Okamura, T., Taguchi, T., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100295118 · Cited by 49
From metabolic byproduct to immune modulator: the role of lactate in tumor immune escape
Jiang, M., Wang, Y., Zhao, X., & Yu, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1492050 · Cited by 54
SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells
Bharadwaj, S., Singh, M. V., Kirtipal, N., & Kang, S. G. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.627842 · Cited by 50
The role of branched chain amino acids metabolic disorders in tumorigenesis and progression
Wang, J., Wang, W., Zhu, F., & Duan, Q. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113390 · Cited by 51
Targeting KRAS mutations in pancreatic cancer: opportunities for future strategies
Linehan, A., O’Reilly, M., McDermott, R., & O'Kane, G. M. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1369136 · Cited by 57
Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?
Seyfried, T. N., Shelton, L. M., Arismendi-Morillo, G., Kalamian, M., Elsakka, A. M., Maroon, J. C., & Mukherjee, P. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02795-4 · Cited by 50
Glutaminolysis and Glycolysis Are Essential for Optimal Replication of Marek’s Disease Virus
Boodhoo, N., Kamble, N. M., Sharif, S., & Behboudi, S. (2019) · Journal of Virology · doi:10.1128/jvi.01680-19 · Cited by 49
GLS1 depletion inhibited colorectal cancer proliferation and migration via redox/Nrf2/autophagy-dependent pathway
Liu, H.-Y., Zhang, H.-S., Liu, M.-Y., Li, H., Wang, X., & Wang, M. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.108964 · Cited by 48
Metabolic pathways utilized by the porcine conceptus, uterus, and placenta
Johnson, G. A., Seo, H., Bazer, F. W., Wu, G., Kramer, A. C., McLendon, B. A., & Cain, J. W. (2022) · Molecular Reproduction and Development · doi:10.1002/mrd.23570 · Cited by 48
The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets
Steiner, N., Müller, U., Hájek, R., Ševčı́ková, S., Borjan, B., Jöhrer, K., Göbel, G., Pircher, A., & Gunsilius, E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202045 · Cited by 49
Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol
Olivas-Aguirre, M., Torres-López, L., Pottosin, I. I., & Dobrovinskaya, O. R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.617937 · Cited by 49
Molecular mechanisms of right ventricular dysfunction in pulmonary arterial hypertension: focus on the coronary vasculature, sex hormones, and glucose/lipid metabolism
Agrawal, V., Lahm, T., Hansmann, G., & Hemnes, A. R. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-404 · Cited by 50
MYCN and Metabolic Reprogramming in Neuroblastoma
Bansal, M., Gupta, A., & Ding, H. (2022) · Cancers · doi:10.3390/cancers14174113 · Cited by 51
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Gharib, E., & Robichaud, G. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179463 · Cited by 55
Meal for Two: Human Cytomegalovirus-Induced Activation of Cellular Metabolism
Rodríguez-Sánchez, I., & Munger, J. C. (2019) · Viruses · doi:10.3390/v11030273 · Cited by 48
Human-Specific Genes, Cortical Progenitor Cells, and Microcephaly
Heide, M., & Huttner, W. Β. (2021) · Cells · doi:10.3390/cells10051209 · Cited by 46
Glutamine metabolism: from proliferating cells to cardiomyocytes
Shen, Y., Zhang, Y., Li, W., Chen, K., Xiang, M., & Ma, H. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154778 · Cited by 44
NMDA Receptor and Its Emerging Role in Cancer
Gallo, S., Vitacolonna, A., & Crepaldi, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032540 · Cited by 47
Rescue from galactose-induced death of Leigh Syndrome patient cells by pyruvate and NAD+
Iannetti, E. F., Smeitink, J. A. M., Willems, P. H. G. M., Beyrath, J., & Koopman, W. J. H. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1179-4 · Cited by 46
Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer
Wang, L., Liu, Y., Zhao, T., Li, Z., He, J., Zhang, B.-J., Du, H., Jiang, J., Yuan, S., & Sun, L. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.12.011 · Cited by 45
Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases
Kumar, M. A., Baba, S. K., Khan, I. R., Khan, M. S., Husain, F. M., Ahmad, S., Haris, M., Singh, M., Akil, A. A., Macha, M. A., et al. (2025) · MedComm · doi:10.1002/mco2.70120 · Cited by 52
Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma
Chu, J., Niu, X., Chang, J., Shao, M., Peng, L., Xi, Y., Lin, A., Wang, C., Cui, Q., Luo, Y., et al. (2020) · Theranostics · doi:10.7150/thno.41427 · Cited by 44
Crosstalk between arginine, glutamine, and the branched chain amino acid metabolism in the tumor microenvironment
Wetzel, T. J., Erfan, S. C., Figueroa, L. D., Wheeler, L. M., & Ananieva, E. A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1186539 · Cited by 46
The role of transporters in cancer redox homeostasis and cross-talk with nanomedicines
Kou, L., Jiang, X., Huang, H., Lin, X., Zhang, Y., Yao, Q., & Chen, R. (2020) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2020.02.001 · Cited by 43
Salivary metabolomics with machine learning for colorectal cancer detection
Kuwabara, H., Katsumata, K., Iwabuchi, A., Udo, R., Tago, T., Kasahara, K., Mazaki, J., Enomoto, M., Ishizaki, T., Soya, R., et al. (2022) · Cancer Science · doi:10.1111/cas.15472 · Cited by 42
The crisscross between p53 and metabolism in cancer
Mao, Y., & Jiang, P. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023109 · Cited by 45
Metabolomics at the tumor microenvironment interface: Decoding cellular conversations
Berrell, N., Sadeghirad, H., Blick, T., Bidgood, C. L., Leggatt, G. R., O'Byrne, K. J., & Kulasinghe, A. (2023) · Medicinal Research Reviews · doi:10.1002/med.22010 · Cited by 44
Activation of polyamine catabolism promotes glutamine metabolism and creates a targetable vulnerability in lung cancer
Han, X., Wang, D., Liao, Y., Wang, N., Shen, J., Wang, J., Zhang, L., Chen, L., Gao, S., Zong, W., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2319429121 · Cited by 46
Mitochondria as emerging targets for therapies against T cell acute lymphoblastic leukemia
Olivas-Aguirre, M., Pottosin, I. I., & Dobrovinskaya, O. R. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.5vmr0818-330rr · Cited by 42
Targeting age‐specific changes in CD4+ T cell metabolism ameliorates alloimmune responses and prolongs graft survival
Nian, Y., Iske, J., Maenosono, R., Minami, K., Heinbokel, T., Quante, M., Yang, L., Azuma, H., Yang, J., Abdi, R., et al. (2021) · Aging Cell · doi:10.1111/acel.13299 · Cited by 42
Self-citation
Metabolic Reprogramming in Hematologic Malignancies: Advances and Clinical Perspectives
Yu, Z., Zhou, X., & Wang, X. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0917 · Cited by 42
Immunonutrition: facilitating mucosal immune response in teleost intestine with amino acids through oxidant-antioxidant balance
Hissen, K. L., He, W., Wu, G., & Criscitiello, M. F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1241615 · Cited by 41
Amino acid catabolite markers for early prognostication of pneumonia in patients with COVID-19
Maeda, R., Seki, N., Uwamino, Y., Wakui, M., Nakagama, Y., Kido, Y., Sasai, M., Taira, S., Toriu, N., Yamamoto, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-44266-z · Cited by 44
Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment
Zheng, X., Mansouri, S., Krager, A., Grimminger, F., Seeger, W., Pullamsetti, S. S., Wheelock, C. E., & Savai, R. (2020) · European Respiratory Review · doi:10.1183/16000617.0134-2020 · Cited by 41
Reprogramming of mitochondrial proline metabolism promotes liver tumorigenesis
Ding, Z., Ericksen, R. E., Lee, Q. Y., & Han, W. (2021) · Amino Acids · doi:10.1007/s00726-021-02961-5 · Cited by 43
MyD88 in myofibroblasts regulates aerobic glycolysis‐driven hepatocarcinogenesis via ERK ‐dependent PKM2 nuclear relocalization and activation
Yuan, Q., Zhang, J., Liu, Y., Chen, H., Liu, H., Wang, J., Niu, M., Hou, L., Wu, Z., Chen, Z., et al. (2021) · The Journal of Pathology · doi:10.1002/path.5856 · Cited by 41
Curcumin Synergizes with Cisplatin to Inhibit Colon Cancer through Targeting the MicroRNA-137-Glutaminase Axis
Fan, W.-H., Wang, F., Jin, Z., Zhu, L., & Zhang, J. (2021) · Current Medical Science · doi:10.1007/s11596-021-2469-0 · Cited by 41
Metabolic advantages of regulatory T cells dictated by cancer cells
Kondo, M., Kumagai, S., & Nishikawa, H. (2023) · International Immunology · doi:10.1093/intimm/dxad035 · Cited by 42

Authors: Yang, L., Venneti, S., & Nagrath, D.
Affiliations: Rice University (US)
University of Michigan (US)
ORCID: Yang, Lifeng
Venneti, Sriram
Nagrath, Deepak
Venue: Annual Review of Biomedical Engineering
Publisher: Annual Reviews
Published: 2017-06-21
Volume: 19
Issue: 1
Pages: 163-194
ISSN: 1523-9829 (ISSN-L)
1545-4274
DOI: 10.1146/annurev-bioeng-071516-044546
OpenAlex: W2534904302
Cited by: 859
References: 171
Citations by year: 2026: 68 · 2025: 140 · 2024: 137 · 2023: 132 · 2022: 126 · 2021: 98 · 2020: 71 · 2019: 46 · 2018: 28 · 2017: 13
FWCI: 4.43
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Annual Review of Biomedical Engineering (publishedVersion)
PubMed (publishedVersion)
Rice Research Repository (Rice University) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
Keywords: glutamine metabolism, glutaminolysis, cancer metabolism, tumor microenvironment, oncogenes, tumor suppressor, metastasis, global DNA methylation, tumor cell proliferation, metabolic therapy, reactive oxygen species, purine and pyrimidine synthesis, signal transduction
MeSH terms: Animals, Cell Transformation, Neoplastic, Glutamine, Humans, Mitochondria, Models, Biological, Neoplasms, Biomarkers, Tumor, Signal Transduction, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Glutaminolysis: A Hallmark of Cancer Metabolism

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks